user

STRESS PREDICTS TRAJECTORIES OF PSYCHOLOGICAL AND PHYSICAL FUNCTIONING IN RELAPSED/REFRACTORY CHRONIC LYMPHOCYTIC LEUKEMIA

被引：0
|
作者：
Goyal, Neha [1 ]
Westbrook, Travis [2 ]
Andersen, Barbara L. [2 ]
机构：
[1] VA Palo Alto, Cupertino, CA USA
[2] Ohio State Univ, Columbus, OH 43210 USA
来源：
ANNALS OF BEHAVIORAL MEDICINE | 2016年 / 50卷
关键词：
D O I：
暂无
中图分类号：
B84 [心理学];
学科分类号：
04 ; 0402 ;
摘要：
D004
引用
收藏
页码：S288 / S288
页数：1
相关论文
共 50 条
  • [21] Lenalidomide active in patients with refractory or relapsed chronic lymphocytic leukemia
    Nature Clinical Practice Oncology, 2007, 4 (3): : 143 - 143
  • [22] Economic burden of relapsed/refractory chronic lymphocytic leukemia.
    Guerin, Annie
    Ray, Saurabh
    Gauthier, Genevieve
    Hsu, Ling-I
    Zhdanava, Maryia
    Heroux, Julie
    Wu, Eric Qiong
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [23] Ofatumumab and Complement Replacement in Relapsed/Refractory Chronic Lymphocytic Leukemia
    Tuscano, Joseph
    Poh, Christina
    Rosenberg, Aaron
    Jonas, Brian
    Abedi, Mehrdad
    Barisone, Gustavo
    Schwab, Emily
    Lundeberg, Kathleen
    Kaesberg, Paul
    JOURNAL OF HEMATOLOGY, 2020, 9 (03) : 79 - 83
  • [24] CLADRIBINE IN THE TREATMENT OF RELAPSED OR REFRACTORY CHRONIC LYMPHOCYTIC-LEUKEMIA
    TALLMAN, MS
    HAKIMIAN, D
    ZANZIG, C
    HOGAN, DK
    RADEMAKER, A
    ROSE, E
    VARIAKOJIS, D
    JOURNAL OF CLINICAL ONCOLOGY, 1995, 13 (04) : 983 - 988
  • [25] The role of idelalisib in the treatment of relapsed and refractory chronic lymphocytic leukemia
    Nair, Kruti Sheth
    Cheson, Bruce
    THERAPEUTIC ADVANCES IN HEMATOLOGY, 2016, 7 (02) : 69 - 84
  • [26] Venetoclax and ibrutinib for patients with relapsed/refractory chronic lymphocytic leukemia
    Niemann, Carsten U.
    Levin, Mark-David
    Dubois, Julie
    Kersting, Sabina
    Enggaard, Lisbeth
    Veldhuis, Gerrit J.
    Mous, Rogier
    Mellink, Clemens H. M.
    Dobber, Johan A.
    Poulsen, Christian B.
    Frederiksen, Henrik
    Janssens, Ann
    Schjodt, Ida
    Dompeling, Ellen C.
    Ranti, Juha
    Mattsson, Mattias
    Bellido, Mar
    Tran, Hoa T. T.
    Nasserinejad, Kazem
    Kater, Arnon P.
    BLOOD, 2021, 137 (08) : 1117 - 1120
  • [27] Ofatumumab for newly diagnosed and relapsed/refractory chronic lymphocytic leukemia
    Reagan, John L.
    Castillo, Jorge J.
    EXPERT REVIEW OF ANTICANCER THERAPY, 2011, 11 (02) : 151 - 160
  • [28] Optimizing Treatment of Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
    Mato, Anthony
    JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2022, 20 (5.5): : 581 - 583
  • [29] Response assessment to venetoclax in relapsed/refractory chronic lymphocytic leukemia by ultrasonography
    Benedetti, Edoardo
    Barate, Claudia
    Bruno, Benedetto
    Bramanti, Emilia
    Ghia, Paolo
    Scarfo, Lydia
    Morganti, Riccardo
    Ricchiuto, Vittorio
    Galimberti, Sara
    LEUKEMIA RESEARCH, 2021, 100
  • [30] ANALYSIS OF TREATMENT OPTIONS FOR RELAPSED OR REFRACTORY CHRONIC LYMPHOCYTIC LEUKEMIA (CLL)
    Sallum, R.
    Dorman, E.
    Xu, Y.
    Tran-Kerr, K.
    O'Donnell, M.
    Sorensen, S.
    Szatkowski, A.
    Sengupta, N.
    Gaudig, M.
    VALUE IN HEALTH, 2014, 17 (07) : A616 - A616
12345